Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Pfizer
PFE
|
+$1.44B |
| 2 |
Eli Lilly
LLY
|
+$878M |
| 3 |
Blackstone
BX
|
+$707M |
| 4 |
RTX Corp
RTX
|
+$596M |
| 5 |
American Express
AXP
|
+$553M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$3.55B |
| 2 |
American Tower
AMT
|
+$1.27B |
| 3 |
Amazon
AMZN
|
+$735M |
| 4 |
TSS
Total System Services, Inc.
TSS
|
+$714M |
| 5 |
NextEra Energy, Inc.
NEE
|
+$621M |
Sector Composition
| 1 | Healthcare | 21.49% |
| 2 | Financials | 15.09% |
| 3 | Technology | 13.78% |
| 4 | Industrials | 11% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Radian Group
RDN
$4.81B
| $25.3M | 0.01% |
1,107,724
-92,663
| -8% | -$2.12M |
|
902
KKR & Co
KKR
$130B
| $25.2M | 0.01% |
940,391
-2,028,949
| -68% | -$54.5M |
|
|
NVTA
903
DELISTED
Invitae Corporation
NVTA
| $25.2M | 0.01% |
1,306,029
-1,795,007
| -58% | -$34.6M |
|
904
Veracyte
VCYT
$2.51B
| $25.1M | 0.01% |
+1,047,487
| New | +$25.1M |
|
905
Emerson Electric
EMR
$76.9B
| $25.1M | 0.01% |
375,528
+325,092
| +645% | +$21.7M |
|
906
Cyclerion Therapeutics
CYCN
$7.85M
| $24.7M | 0.01% |
101,960
-3,414
| -3% | -$828K |
|
907
CGI
GIB
$20.8B
| $24.6M | 0.01% |
311,197
+1,154
| +0.4% | +$91.3K |
|
908
Fomento Económico Mexicano
FMX
$30.9B
| $24.6M | 0.01% |
268,498
+176,982
| +193% | +$16.2M |
|
909
Trade Desk
TTD
$22.3B
| $24.5M | 0.01% |
1,305,580
-2,337,760
| -64% | -$43.8M |
|
910
BrightView Holdings
BV
$1.34B
| $24.4M | 0.01% |
1,425,005
-142,367
| -9% | -$2.44M |
|
|
XEC
911
DELISTED
CIMAREX ENERGY CO
XEC
| $24.3M | 0.01% |
507,213
-101,784
| -17% | -$4.88M |
|
912
Caesarstone
CSTE
$49.8M
| $24.2M | 0.01% |
1,454,799
-11,659
| -0.8% | -$194K |
|
913
Acadia Realty Trust
AKR
$2.58B
| $24.1M | 0.01% |
843,276
-44,497
| -5% | -$1.27M |
|
914
Rhythm Pharmaceuticals
RYTM
$6.66B
| $24.1M | 0.01% |
1,114,347
+571,717
| +105% | +$12.3M |
|
915
Atlanta Braves Holdings Series B
BATRK
$2.64B
| $24M | 0.01% |
865,088
-13,300
| -2% | -$369K |
|
916
Warrior Met Coal
HCC
$3.12B
| $24M | 0.01% |
1,229,174
+667,665
| +119% | +$13M |
|
|
CVA
917
DELISTED
Covanta Holding Corporation
CVA
| $23.8M | 0.01% |
1,375,431
+91,233
| +7% | +$1.58M |
|
918
Acadia Pharmaceuticals
ACAD
$4.06B
| $23.8M | 0.01% |
660,068
+631,942
| +2,247% | +$22.7M |
|
919
Zoetis
ZTS
$66.5B
| $23.7M | 0.01% |
189,826
+13,629
| +8% | +$1.7M |
|
920
A.O. Smith
AOS
$10.4B
| $23.6M | 0.01% |
494,538
+317,421
| +179% | +$15.1M |
|
921
ICU Medical
ICUI
$3.31B
| $23.6M | 0.01% |
147,585
-39,297
| -21% | -$6.27M |
|
922
Cato Corp
CATO
$89.8M
| $23.4M | 0.01% |
1,326,334
-149,553
| -10% | -$2.63M |
|
923
Syndax Pharmaceuticals
SNDX
$1.4B
| $23.1M | 0.01% |
3,097,523
-179,759
| -5% | -$1.34M |
|
924
Arcus Biosciences
RCUS
$1.25B
| $23.1M | 0.01% |
2,541,117
-109,092
| -4% | -$993K |
|
925
US Physical Therapy
USPH
$1.25B
| $23.1M | 0.01% |
176,972
-3,774
| -2% | -$493K |
|